About
Basic Data Updated:
4 months agoIt is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543245 and on the National Stock Exchange(NSE) under GLAND.
The Corporate was formerly known as Gland Pharma Pvt Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized ... Read More
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Financials of Gland Pharma Ltd
Enhance accessibility to Gland Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Gland Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Gland Pharma Ltd
Unlock and access historical data on people associated with Gland Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
SS
Srinivas Sadu
Managing DirectorAppointment Date: 17-Jun-2014
Status: Current
RM
Ravi Mitra CFOAppointment Date: 30-Sep-2019
Status: Current
SP
Sampath Pallerlamudi Company SecretaryAppointment Date: 17-Dec-2013
Status: Current
Board Members(8)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 10 Sep 2012 | ₹100.00 Cr | Satisfied |
Syndicate Bank Creation Date: 30 Jun 2012 | ₹100.00 Cr | Satisfied |
The Bank Of Nova Scotia Creation Date: 06 Sep 2005 | ₹140.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gland Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gland Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Frontizo Business Services Private Limited
Active
12 years 28 days Essaji Vahanvati is a mutual person
Satyarx Pharma Innovations Private Limited
Active 3 years 8 months Satyanarayana Chavali is a mutual person
Recent activity within the organization
Annual General Meeting
Gland Pharma Ltd last Annual general meeting of members was held on 31 Aug 2023 as per latest MCA records.
31 Aug 2023Balance Sheet
Gland Pharma Ltd has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Director Appointment
Naina Lal Kidwai was appointed as a Director was appointed as a Director on 17 May 2021 & has been associated with this company since 2 years 11 months .
17 May 2021Director Appointment
Essaji Goolam Vahanvati was appointed as a Director was appointed as a Director on 30 Sep 2020 & has been associated with this company since 3 years 6 months .
30 Sep 2020Director Appointment
Yiu Kwan Stanley Lau was appointed as a Director was appointed as a Director on 10 Jun 2019 & has been associated with this company since 4 years 10 months .
10 Jun 2019
Recent News, Updates & Announcement
Gland Pharma receives Establishment Inspection Report from USFDA for Pashamylaram facility.India Infoline 01 Oct 2023
- Gland Pharma net declines even as Cenexi helps push up revenue.
The Hindu 08 Aug 2023
- Gland Pharma Hyderabad facility gets 1 observation from USFDA stock gains 3.
The inspection was concluded with one 483 Observation.
Moneycontrol 15 Jul 2023
- Indias Gland Pharma reports lower Q4 profit on soft demand.
Reuters 18 May 2023
- Chinas Fosun drops plan to sell stake in drugmaker Gland Pharma.
Business Standard 26 Apr 2023
Frequently asked questions
What is the Incorporation or founding date of Gland Pharma Ltd?
